GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash and Bank History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹1,404 Cr | ₹1,063 Cr | ₹1,156 Cr | ₹2,485 Cr | ₹1,158 Cr |
What is the latest Cash and Bank ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Cash and Bank |
|---|---|
| Mar2025 | ₹1,404 Cr |
| Mar2024 | ₹1,063 Cr |
| Mar2023 | ₹1,156 Cr |
| Mar2022 | ₹2,485 Cr |
| Mar2021 | ₹1,158 Cr |
How is Cash and Bank of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,404 Cr | 32.01 | |
| Mar2024 | ₹1,063 Cr | -8.02 | |
| Mar2023 | ₹1,156 Cr | -53.47 | |
| Mar2022 | ₹2,485 Cr | 114.56 | |
| Mar2021 | ₹1,158 Cr | - | |
Compare Cash and Bank of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹40,783.9 Cr | 2.9% | -2.6% | 16.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,341.0 Cr | -1.8% | -6.4% | -10.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,401.0 Cr | -0.3% | -5.5% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,175.0 Cr | -0.1% | 4% | 18.7% | Stock Analytics | |
| CIPLA | ₹107,100.0 Cr | 1% | -12.3% | -5.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,715.9 Cr | -4.6% | -7% | 1.8% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 2.9% |
-2.6% |
16.2% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses